Qube Research & Technologies Ltd

Position in CCCC — C4 Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in CCCC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,730,487

-$247,572 QoQ

Shares Held

370,554

-50.7% QoQ

Ownership

0.301%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#44

of 147 holders

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,068,185 across 169 Biotechnology names. CCCC ranks #105 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,730,487	370,554	-50.7%	Shares	Sole	2026-08-14
2026-03-31	$1,978,059	752,114	+159.1%	Shares	Sole	2026-05-15
2025-12-31	$554,346	290,234	+150.3%	Shares	Sole	2026-02-17
2025-09-30	$257,460	115,973	-55.1%	Shares	Sole	2025-11-14
2024-06-30	$1,193,928	258,426	-33.4%	Shares	Sole	2024-08-14
2024-03-31	$3,171,536	388,193	+1333.0%	Shares	Sole	2024-05-14
2023-12-31	$153,058	27,090	+293.4%	Shares	Sole	2024-02-13
2023-09-30	$12,807	6,886	-91.0%	Shares	Sole	2023-11-13
2023-06-30	$211,150	76,782	+158.6%	Shares	Sole	2023-08-14
2023-03-31	$93,220	29,688	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.